Printer Friendly

OraSure Salutes National Black HIV/AIDS Awareness and Information Day with OraQuick Rapid Testing Initiative on February 7th.

Business Editors/Health/Medical Writers

BETHLEHEM, Pa.--(BUSINESS WIRE)--Feb. 6, 2004

OraSure Partners with HIV Testing Sites Across the Country to Encourage Rapid HIV Testing with OraQuick(R)

OraSure Technologies, Inc. (Nasdaq NM:OSUR), the market leader in oral fluid diagnostics, announced today that its OraQuick(R) Rapid HIV-1 Antibody Test will be utilized by numerous locations across the United States to conduct free HIV testing in observance of National Black HIV/AIDS Awareness and Information Day on February 7, 2004.

February 7, 2004, is the fourth annual observance of National Black HIV/AIDS Awareness and Information Day. This national mobilization effort is designed to encourage African Americans across the United States and Territorial Areas to get educated, get tested and get involved with HIV/AIDS.

OraSure is working with a number of clinics throughout the country and has specifically partnered with the following sites in observance of National Black HIV/AIDS Awareness and Information Day, which will be offering free HIV testing with the OraQuick(R) Rapid HIV-1 Antibody Test:

-- Ebony House, Phoenix, Arizona

-- Our Common Welfare, Decatur, Georgia

-- Matthew 25 AIDS Services, Inc., Henderson, Kentucky

-- St. Michael's Medical Center, Newark, New Jersey

-- Renaissance III, Dallas, Texas

-- Hope Action Care, San Antonio, Texas

"We are honored to be working with dedicated organizations across the country for National Black HIV/AIDS Awareness and Information Day to help stem the spread of HIV," said Mike Gausling, Chief Executive Officer of OraSure Technologies. "As the only FDA-approved, CLIA (Clinical Laboratory Improvements Amendments of 1988) waived, rapid point-of-care HIV-1 test, we hope OraQuick(R) will help increase the number of people who get tested and learn their HIV results. We will continue to work in partnership with local, state and national agencies to help make this happen."

OraQuick(R) is a rapid, point-of-care test designed to detect antibodies to HIV-1 within 20 minutes. OraSure has received FDA approval for use of the OraQuick(R) device in testing finger-stick and venipuncture whole blood specimens for antibodies to HIV-1. In addition, OraSure has received a CLIA waiver for this test, thereby permitting the test to be used in more than 180,000 sites in the United States, such as outreach clinics, community-based organizations and physicians' offices.

National Black HIV/AIDS Awareness and Information Day is co-founded and sponsored by Concerned Black Men of Philadelphia, Jackson State University - Mississippi Urban Research Center, Health Watch Information and Promotion Service, National Black Alcoholism and Addictions Council, and the National Black Leadership Commission on AIDS. This group is commonly referred to as the Community Capacity Building Coalition, and is currently funded by the Centers for Disease Control and Prevention ("CDC"). More information can be found at www.blackaidsday.org.

About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices and tests and other diagnostic products using its proprietary technologies, including immunoassays and other in vitro diagnostic tests and other medical devices. These products are sold in the United States and certain foreign countries to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.

OraSure Technologies is the leading supplier of oral-fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV-1. In addition, the Company supplies oral-fluid testing solutions for drugs of abuse testing. For more information on the Company, please go to www.orasure.com.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 6, 2004
Words:574
Previous Article:Co-Stars of ``Fallacy'' to Make Appearance at Directors Guild Awards.
Next Article:Equitex Appoints New Board Member.
Topics:


Related Articles
Rapid HIV test--how available should it be? (On First Reading).
Trials and tribulations: disappointing results from the first-ever human AIDS vaccine trial leave researchers asking what's next. (AIDS Research).
BRIEFLY GIRL, 15, DIES AFTER COCAINE OVERDOSE.
Testing times: the importance of identifying HIV infections before it's too late.
Theme for International Nurses' Day.
African-Americans and AIDS conference, Philadelphia, Feb. 23-24.
Over-the-counter HIV test has drawbacks.
BRIEFLY.
Quick result, but often false.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters